Computer Vision News - November 2018

19 IDG-DREAM Drug Kinase Binding Prediction We asked Tero Aittokallio , Professor of Statistics and Applied Mathematics at the Department of Mathematics and Statistics of the University of Turku (Finland) and FIMM-EMBL Group Leader to tell us more about DREAM and about the challenge. Here is the answer that Tero, co-organizer of the challenge, gave us: “ If your readers are not familiar with the DREAM challenges , here is a general introduction: DREAM is a non-profit organization that sponsors scientific competitions , so-called crowdsourced challenges, which pose fundamental questions about systems biology and translational medicine. The Challenges are designed and run by a community of researchers from a variety of organizations, and the solutions (e.g., machine learning models) are tested by the organizers using independent data . This allows individuals and teams to collaborate openly so that the “wisdom of the crowd” provides the greatest impact on science and human health.” When asked about the vision behind the challenge, Tero replied: “We envision that the IDG-DREAM Challenge will provide a continuously-updated resource of predictive models and experimental data for the chemical biology community to prioritize and experimentally test new target selectivities toward accelerating exciting drug discovery and repurposing applications.” The challenge page is here . Good luck! Challenge Computer Vision News “…a continuously- updated resource of predictive models and experimental data for the chemical biology community…” Anna Cichonska